scispace - formally typeset
M

Michael Karin

Researcher at University of California, San Diego

Publications -  753
Citations -  246120

Michael Karin is an academic researcher from University of California, San Diego. The author has contributed to research in topics: IκB kinase & Signal transduction. The author has an hindex of 236, co-authored 704 publications receiving 226485 citations. Previous affiliations of Michael Karin include Sanford-Burnham Institute for Medical Research & University of California, Los Angeles.

Papers
More filters
Journal ArticleDOI

The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase.

TL;DR: It is found that As3+, but not As5+, is a potent stimulator of AP‐1 transcriptional activity and an efficient inducer of c‐fos and c‐jun gene expression and the primary mechanism by which As3+ stimulates JNK activity involves the inhibition of a constitutive dual‐specificity JNK phosphatase.
Journal ArticleDOI

Loss of hepatic NF-κB activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation

TL;DR: It is suggested that the control of tissue renewal through the IKK and JNK pathways plays a key role in liver carcinogenesis.
Journal ArticleDOI

JNK2 and IKKβ Are Required for Activating the Innate Response to Viral Infection

TL;DR: A general role is established for IKKbeta and JNK2 are essential for efficient induction of type I IFN and other cytokines in response to viral infection or dsRNA and a pathway leading to NF-kappaB is described.
Journal ArticleDOI

From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance.

TL;DR: The c‐Jun N‐terminal kinases (JNKs) were originally identified by their ability to phosphorylate c‐ Jun in response to UV‐irradiation, but now are recognized as critical regulators of various aspects of mammalian physiology, including: cell proliferation, cell survival, cell death, DNA repair and metabolism.